Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis
AUTOR(ES)
Lima, Giana da Silveira, Silva, Gabriela Ferrari da, Gomes, Ana Paula Neutzling, Araújo, Lenita Maria Aver de, Salum, Fernanda Gonçalves
FONTE
Journal of Applied Oral Science
DATA DE PUBLICAÇÃO
2010-10
RESUMO
OBJECTIVE: Actinic cheilitis (AC) is a precancerous lesion of the lip vermillion caused by prolonged exposure to ultraviolet light. The aim of this study was to evaluate the effect of 3% diclofenac in 2.5% hyaluronic acid gel in the treatment of AC. METHODS: Thirty-four patients with chronic AC were treated twice a day with topical diclofenac during a period of 30 to 180 days. The individuals were followed up every 15 days by means of clinical examination and digital photographic documentation. RESULTS: Of the 27 patients that completed the study, 12 (44%) showed complete remission of the whitish plaques and exfoliative areas, and 15 (56%) had partial remission of the clinical picture of cheilitis. The latter group was submitted to excision of the leukoplakic areas which diagnosis varied from mild to moderate epithelial dysplasia. CONCLUSIONS: The results suggest a promising role for diclofenac in hyaluronic acid gel in the treatment of AC. This treatment has the advantages of not being invasive and showing few side effects.
Documentos Relacionados
- Carbon dioxide laser treatment of actinic cheilitis.
- Clinical and histopathological study of actinic cheilitis
- p53 and MDM2 protein expression in actinic cheilitis
- Silica gel: an improved support for the solid-phase phosphotriester synthesis of oligonucleotides.
- Prevalence of and Factors Associated with Actinic Cheilitis in Extractive Mining Workers